Antibiotic resistance of Acinetobacter baumannii isolates: Data from Ibni Sina Hospital in the year 2002;Acinetobacter baumannii i̇zolatlarinda anti̇bi̇yoti̇k di̇renci̇: 2002 Yili İbni̇ Si̇na Hastanesi̇ veri̇leri̇

Mikrobiyoloji Bulteni

Volumn 37, Issue 4, 2003, Pages 241-246

  Arikan Akan, Özay ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Acinetobacter baumannii; Antibiotic resistance

Indexed keywords

AMIKACIN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; SULTAMICILLIN; TICARCILLIN; TIMENTIN; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ABSCESS; ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; EMERGENCY WARD; HOSPITAL INFECTION; INFECTION CONTROL; INTENSIVE CARE; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT INFECTION; NONHUMAN; RESUSCITATION; SEPSIS; TURKEY (REPUBLIC); URINARY TRACT INFECTION; ADULT; CROSS INFECTION; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; TURKEY;

EID: 3042775472     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bergogne-Berezin E, Tower K: Acinetobacter spp. as nosocomial pathogens, microbiological, clinical and epidemiological features. Clin Microbiol Rev 1996, 9: 148-165.
2. Towner KJ: Clinical importance and antibiotic resistance of Acinetobacter spp. J Med Microbiol 1997, 24: 584-602.
3. Konemann EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC (Eds): Color Atlas and Textbook of Diagnostic Microbiology. 1992, 4th ed. JB Lippincott Company, Philadelphia.
4. National Committee for Control of Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests. 1990, 4th ed. Approved Standard M2-A4, NCCLS, Villanova, Pa.
5. Rubinstein E, Levy I: Acinetobacter spp. and other non-fermentative pathogens causing nosocomial bacteremias. Clin Microbiol Infect 1999, 5: 29-32.
6. Yalçin AN: Nozokomiyal Gram negatif çomak infeksiyonlan. Klimik Derg 2000, 13: 23-25.
7. Gür D, Ünal S ve ark: Yoǧun bakim ünitererinden izole edilen Gram negatif bakterilerin çeşitli antibiyotiklere in vitro duyarliliklan. Flora 1996, 3: 153-159.
8. Aygün G, Utku T, Dikmen Y ve ark: Yoǧun Bakim Ünitesinde kan kültüründen izole edilen mikroorganizmalar. Flora 2002, 7: 94-98.
9. Ciisneros JM, Reyes MJ, Pachon J, et al: Bacteremia due to Acinetobacter baumannii: Epidemiology, clinical findings and prognostic features. Clin Infect Dis 1996, 22: 1026-1032.
10. Chastre J, Trouillet JL: Problem pathogens (Pseudomonas aeruginosa and Acinetobacter). Semin Respir Infect 2000, 15: 287-298.
11. Gütay Z: Antibiyotiklere direnç mekanizmatan ve çözüm önerileri: Beta-laktamlara ve karbapenemlere direng. Hastane Infeksiyonlan Derg 2001, 5: 210-229.
12. th ed Churchill Livingstone, New York.
13. Arda B, Yamazhan T, Ulusoy S, Öziner MA: Yoǧun bakim ünitelerinde izole edilen P.aeruginosa ve Acinetobacter türlerinin antibiyotik duyarliliǧindaki dört yilik deǧişim (1995-1999). Hastane infeksiyonlan Derg 2001, 5: 49-53.
14. Atay T, Bigmen M, Gülay Z: Kan kültürlerinden izole edilen Gram negatif nonfermentatif çomaklar ve antibiyotik duyarlililan. ANKEM Derg 2002, 16: 108.
15. Bal Ç: Beta-laktamazlar: Güncel durum. Flora 2003, 8: 111-123.
16. Livermore DM, Woodford N: Carbapenemases: A problem waiting? Curr Opin Microbiol 2000, 3: 489-495.
17. Hancock REW: Resistance mechanisms in Pseudomonas aeruginosa and non-fermentative Gram-negative bacteria. Clin Infect Dis 1998, 27 (Suppl 1): 93-99.
18. Mendes C, Hsiung A, Kiffer C, et al and Mystic Study Group: Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in Brazil. Mystic Antimicrobial Surveillance Program. Braz J Infect Dis 2000, 4: 236-244.
19. Özgüneş N, Aydin ÖŞ, Ergen P, Ceylan N, Özsoy A, Aydin H: Çeştli klinik örneklerden izole edilen Acinetobacter suşlarinin antibiyotik direnci. SSK Göztepe Egitim Hastanesi infeksiyon Hastaliklan Ktiniǧi. Ankem Derg 2002, 16: 110.
20. Öksüz S, Genç L, Günel S, Öngen B, Gürler N: 2002 yilinda kan kültüründen izole edilen mikroorganizmalar ve antibiyotiklere direnç durumu. Ankem Derg 2003, 17: 89.
21. Urban C, Go E, Marino N, et al: Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J Infect Dis 1993, 167: 448-451.
22. Jimenez-Mejias ME, Pachon J, Becerril B, et al: Treatment of multidrug resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam. Clin Infect Dis 1997, 24: 932-935.
23. st century. Clin Infect Dis 2002, 35: 901-902.
24. Go ES, Urban C, Burns J, et al: Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 1994, 344: 1329-1332.
25. Giamarellos-Bourboulis EJ, Karnesis L, Giamarellou H: Synergy of colistin with rifampin and trimetoprim-sulfamethoxazole on multidrug resistant Stenotrophomonas maltophilia. Diagn Microbiol Infect Dis 2002, 44: 250-263.